Xenon Financial Statements From 2010 to 2026

Xenon Pharmaceuticals Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Common Stock Shares Outstanding 94.1 M 89.6 M 34.6 M Slightly volatile Total Assets 963.8 M 917.9 M 349.4 M Slightly volatile Short and Long Term Debt Total 10 M 10.4 M 7.8 M Slightly volatile Other Current Liabilities 28.3 M 27 M 8.9 M Slightly volatile Total Current Liabilities 43 M 40.9 M 20.4 M Slightly volatile Total Stockholder Equity 911.5 M 868.1 M 317.4 M Slightly volatile Other Liabilities 606.2 K 638.1 K 6.4 M Slightly volatile Property Plant And Equipment Net 22 M 20.9 M 8 M Slightly volatile Accounts Payable 3.2 M 5.8 M 2.8 M Slightly volatile Cash 172.3 M 164.1 M 81.5 M Slightly volatile Non Current Assets Total 196.7 M 187.3 M 62.7 M Slightly volatile Cash And Short Term Investments 757 M 720.9 M 282.6 M Slightly volatile Net Receivables 929.5 K 1.7 M 846.3 K Slightly volatile Common Stock Total Equity 1.3 B 1.2 B 477.3 M Slightly volatile Liabilities And Stockholders Equity 963.8 M 917.9 M 349.4 M Slightly volatile Non Current Liabilities Total 7.1 M 6.9 M 11.3 M Slightly volatile Other Current Assets 8.3 M 7.9 M 3.2 M Slightly volatile Total Liabilities 28.8 M 49.7 M 30.6 M Very volatile Property Plant And Equipment Gross 19.5 M 36.4 M 17 M Slightly volatile Total Current Assets 767.1 M 730.6 M 286.7 M Slightly volatile Common Stock 1.8 B 1.7 B 576.5 M Slightly volatile Property Plant Equipment 7.8 M 7.5 M 3.7 M Slightly volatile Capital Surpluse 171.6 M 163.4 M 74.9 M Slightly volatile Long Term Debt Total 11.7 M 12.5 M 9 M Slightly volatile Net Invested Capital 462.5 M 868.1 M 293.7 M Slightly volatile Short and Long Term Debt 2.9 M 5.3 M 2.7 M Slightly volatile Net Working Capital 380.4 M 689.6 M 242.4 M Slightly volatile Short Term Debt 2.5 M 1.2 M 1.9 M Very volatile Capital Stock 900.5 M 1.7 B 617.4 M Slightly volatile Capital Lease Obligations 7.9 M 10.4 M 4.1 M Slightly volatile Deferred Long Term Asset Charges 190.4 K 214.2 K 233.8 K Slightly volatile
Xenon Pharmaceuticals Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 3.1 M 2.9 M 1.4 M Slightly volatile Selling General Administrative 83.2 M 79.2 M 24.7 M Slightly volatile Other Operating Expenses 337.3 M 321.2 M 100.8 M Slightly volatile Research Development 254.1 M 242 M 75.8 M Slightly volatile Total Operating Expenses 334.2 M 318.2 M 90.1 M Slightly volatile Cost Of Revenue 2.8 M 2.9 M 30.3 M Slightly volatile Interest Income 50.6 M 48.2 M 12.9 M Slightly volatile Reconciled Depreciation 3.1 M 2.9 M 1.2 M Slightly volatile Selling And Marketing Expenses 2.8 M 3.2 M 3.5 M Slightly volatile
Xenon Pharmaceuticals Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 61.2 M 58.3 M 15 M Slightly volatile Begin Period Cash Flow 179.5 M 170.9 M 69.3 M Slightly volatile Depreciation 3.1 M 2.9 M 1.4 M Slightly volatile Capital Expenditures 3.7 M 3.5 M 1.7 M Slightly volatile End Period Cash Flow 172.3 M 164.1 M 76 M Slightly volatile Sale Purchase Of Stock 770.2 K 810.8 K 17.9 M Very volatile Issuance Of Capital Stock 10.3 M 10.9 M 108.4 M Very volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 239 228 98.316 Slightly volatile PTB Ratio 2.16 3.64 2.5379 Slightly volatile Days Sales Outstanding 64.67 34.33 56.7021 Very volatile Book Value Per Share 5.52 8.72 7.2293 Pretty Stable Stock Based Compensation To Revenue 2.04 1.94 1.2278 Slightly volatile Capex To Depreciation 1.1 1.08 1.2751 Slightly volatile PB Ratio 2.16 3.64 2.5379 Slightly volatile Payables Turnover 0.55 0.58 10.8874 Very volatile Sales General And Administrative To Revenue 2.65 3.13 3.0415 Pretty Stable Research And Ddevelopement To Revenue 8.74 10.09 9.9326 Pretty Stable Capex To Revenue 0.14 0.28 0.1929 Slightly volatile Cash Per Share 10.49 9.26 13.7785 Slightly volatile Days Payables Outstanding 683 651 177 Slightly volatile Current Ratio 13.26 16.06 14.7718 Slightly volatile Tangible Book Value Per Share 5.52 8.72 7.2293 Pretty Stable Receivables Turnover 10.45 11.0 26.7104 Slightly volatile Shareholders Equity Per Share 5.52 8.72 7.2293 Pretty Stable Debt To Equity 0.013 0.0137 0.1039 Slightly volatile Capex Per Share 0.0431 0.0454 0.0876 Slightly volatile Graham Net Net 4.63 6.76 5.9618 Pretty Stable Revenue Per Share 0.17 0.18 1.7728 Slightly volatile Interest Debt Per Share 0.13 0.1157 0.4722 Slightly volatile Debt To Assets 0.0123 0.013 0.0673 Slightly volatile Graham Number 7.77 9.47 9.913 Pretty Stable Operating Cycle 64.67 34.33 56.7021 Very volatile Price Book Value Ratio 2.16 3.64 2.5379 Slightly volatile Days Of Payables Outstanding 683 651 177 Slightly volatile Ebt Per Ebit 1.17 0.98 1.0554 Slightly volatile Company Equity Multiplier 1.68 1.22 1.9335 Slightly volatile Long Term Debt To Capitalization 0.13 0.12 0.1228 Slightly volatile Total Debt To Capitalization 0.0129 0.0136 0.0895 Slightly volatile Debt Equity Ratio 0.013 0.0137 0.1039 Slightly volatile Quick Ratio 13.26 16.06 14.7718 Slightly volatile Net Income Per E B T 1.1 1.13 1.0116 Slightly volatile Cash Ratio 7.24 4.61 6.0973 Very volatile Days Of Sales Outstanding 64.67 34.33 56.7021 Very volatile Price To Book Ratio 2.16 3.64 2.5379 Slightly volatile Fixed Asset Turnover 0.61 0.64 3.8976 Slightly volatile Debt Ratio 0.0123 0.013 0.0673 Slightly volatile Price Sales Ratio 239 228 98.316 Slightly volatile Asset Turnover 0.0137 0.0144 0.126 Slightly volatile Price Fair Value 2.16 3.64 2.5379 Slightly volatile
Xenon Pharmaceuticals Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 2.9 B 2.7 B 1 B Slightly volatile

Xenon Fundamental Market Drivers

Xenon Upcoming Events

About Xenon Pharmaceuticals Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Xenon Pharmaceuticals is a strong investment it is important to analyze Xenon Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Xenon Pharmaceuticals' future performance. For an informed investment choice regarding Xenon Stock, refer to the following important reports:

How To Invest In Xenon Details

Is Xenon Stock a good investment? Details

What is Xenon Pharmaceuticals' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details